Dr. Reid W Merryman, MD
Claim this profileDana-Farber Cancer Institute
Studies Cancer
Studies Follicular Lymphoma
7 reported clinical trials
12 drugs studied
Area of expertise
1Cancer
CD20 positive
HLA-A positive
2Follicular Lymphoma
CD20 positive
HLA-A positive
Affiliated Hospitals
Clinical Trials Reid W Merryman, MD is currently running
EZR
for Follicular Lymphoma
The purpose of this study is to determine how effective and safe the combination of epcoritamab, zanubrutinib, and rituximab is in treating participants with relapse or refractory Follicular Lymphoma (FL). * The names of the study drugs involved in this research study are: * Epcoritamab (a type of antibody) * Zanubrutinib (a type of Bruton tyrosine kinase inhibitor) * Rituximab (a type of monoclonal antibody)
Recruiting1 award Phase 25 criteria
Epcoritamab + Rituximab
for Follicular Lymphoma
The purpose of this study is to determine how effective and safe the combination of rituximab and epcoritamab is in treating patients with Follicular Lymphoma (FL) and who have not received other treatments for their lymphoma. The names of the study drugs involved in this study are: * Rituximab (a type of monoclonal antibody therapy) * Epcoritamab (a T-cell bispecific antibody)
Recruiting1 award Phase 2
More about Reid W Merryman, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Reid W Merryman, MD has experience with
- Rituximab
- Epcoritamab
- Pembrolizumab
- Zanubrutinib
- Ipilimumab
- Nivolumab
Breakdown of trials Reid W Merryman, MD has run
Cancer
Follicular Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Reid W Merryman, MD specialize in?
Reid W Merryman, MD focuses on Cancer and Follicular Lymphoma. In particular, much of their work with Cancer has involved CD20 positive patients, or patients who are HLA-A positive.
Is Reid W Merryman, MD currently recruiting for clinical trials?
Yes, Reid W Merryman, MD is currently recruiting for 4 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Reid W Merryman, MD has studied deeply?
Yes, Reid W Merryman, MD has studied treatments such as Rituximab, Epcoritamab, Pembrolizumab.
What is the best way to schedule an appointment with Reid W Merryman, MD?
Apply for one of the trials that Reid W Merryman, MD is conducting.
What is the office address of Reid W Merryman, MD?
The office of Reid W Merryman, MD is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.